Literature DB >> 22875566

Gene transfer in the lung using recombinant adeno-associated virus.

Alisha M Gruntman1, Christian Mueller, Terence R Flotte, Guangping Gao.   

Abstract

Adeno-associated virus (AAV) is a small replication-deficient DNA virus belonging to the Parvovirinae family. It has a single-stranded ∼4.7-kb genome. Recombinant AAV (rAAV) is created by replacing the viral rep and cap genes with the transgene of interest along with promoter and polyadenylation sequences. The short viral inverted terminal repeats must remain intact for replication and packaging in production, as well as vector genome processing and persistence in the transduction process. The AAV capsid (serotype) determines the tissue tropism of the rAAV vector. In this unit we will discuss serotype selection for lung targeting along with the factors effecting efficient delivery of rAAV vectors to the murine lung. Detailed procedures for lung delivery (intranasal, orotracheal, and surgical tracheal injection), sample collection, and post-mortem tissue processing will be described.
© 2012 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22875566      PMCID: PMC3486738          DOI: 10.1002/9780471729259.mc14d02s26

Source DB:  PubMed          Journal:  Curr Protoc Microbiol


  29 in total

1.  Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia.

Authors:  D S Southam; M Dolovich; P M O'Byrne; M D Inman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-04       Impact factor: 5.464

2.  In vivo model of adeno-associated virus vector persistence and rescue.

Authors:  S A Afione; C K Conrad; W G Kearns; S Chunduru; R Adams; T C Reynolds; W B Guggino; G R Cutting; B J Carter; T R Flotte
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors.

Authors:  C L Halbert; J M Allen; A D Miller
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  rAAV human trial experience.

Authors:  Katherine A High; Patrick Aubourg
Journal:  Methods Mol Biol       Date:  2011

5.  Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer.

Authors:  J Zabner; M Seiler; R Walters; R M Kotin; W Fulgeras; B L Davidson; J A Chiorini
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 6.  Rate limiting steps of AAV transduction and implications for human gene therapy.

Authors:  S Sanlioglu; M M Monick; G Luleci; G W Hunninghake; J F Engelhardt
Journal:  Curr Gene Ther       Date:  2001-07       Impact factor: 4.391

7.  Identification of PDGFR as a receptor for AAV-5 transduction.

Authors:  Giovanni Di Pasquale; Beverly L Davidson; Colleen S Stein; Inês Martins; Dominic Scudiero; Anne Monks; John A Chiorini
Journal:  Nat Med       Date:  2003-09-14       Impact factor: 53.440

8.  Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial.

Authors:  Richard B Moss; David Rodman; L Terry Spencer; Moira L Aitken; Pamela L Zeitlin; David Waltz; Carlos Milla; Alan S Brody; John P Clancy; Bonnie Ramsey; Nicole Hamblett; Alison E Heald
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

9.  Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration.

Authors:  T R Flotte; S A Afione; P L Zeitlin
Journal:  Am J Respir Cell Mol Biol       Date:  1994-11       Impact factor: 6.914

10.  Clades of Adeno-associated viruses are widely disseminated in human tissues.

Authors:  Guangping Gao; Luk H Vandenberghe; Mauricio R Alvira; You Lu; Roberto Calcedo; Xiangyang Zhou; James M Wilson
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  6 in total

1.  Optimization of adeno-associated virus vector-mediated gene transfer to the respiratory tract.

Authors:  F Kurosaki; R Uchibori; N Mato; Y Sehara; Y Saga; M Urabe; H Mizukami; Y Sugiyama; A Kume
Journal:  Gene Ther       Date:  2017-03-27       Impact factor: 5.250

2.  Recombinant adeno-associated virus vectors in the treatment of rare diseases.

Authors:  Eric Hastie; R Jude Samulski
Journal:  Expert Opin Orphan Drugs       Date:  2015-05-15       Impact factor: 0.694

3.  AAV5 delivery of CRISPR-Cas9 supports effective genome editing in mouse lung airway.

Authors:  Shun-Qing Liang; Christopher J Walkey; Alexa E Martinez; Qin Su; Mary E Dickinson; Dan Wang; William R Lagor; Jason D Heaney; Guangping Gao; Wen Xue
Journal:  Mol Ther       Date:  2021-10-23       Impact factor: 12.910

4.  Lung gene therapy-How to capture illumination from the light already present in the tunnel.

Authors:  Emily Xia; Manjunatha Ankathatti Munegowda; Huibi Cao; Jim Hu
Journal:  Genes Dis       Date:  2014-09

5.  Targeting the lung epithelium after intravenous delivery by directed evolution of underexplored sites on the AAV capsid.

Authors:  David Goertsen; Nick Goeden; Nicholas C Flytzanis; Viviana Gradinaru
Journal:  Mol Ther Methods Clin Dev       Date:  2022-08-01       Impact factor: 5.849

6.  Intratracheally administered LNA gapmer antisense oligonucleotides induce robust gene silencing in mouse lung fibroblasts.

Authors:  Minwook Shin; Io Long Chan; Yuming Cao; Alisha M Gruntman; Jonathan Lee; Jacquelyn Sousa; Tomás C Rodríguez; Dimas Echeverria; Gitali Devi; Alexandre J Debacker; Michael P Moazami; Pranathi Meda Krishnamurthy; Julia M Rembetsy-Brown; Karen Kelly; Onur Yukselen; Elisa Donnard; Teagan J Parsons; Anastasia Khvorova; Erik J Sontheimer; René Maehr; Manuel Garber; Jonathan K Watts
Journal:  Nucleic Acids Res       Date:  2022-08-26       Impact factor: 19.160

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.